Commentary: COVID-19 and Obesity: Exploring Biologic Vulnerabilities, Structural Disparities, and Weight Stigma

Obesity has emerged as a risk factor for hospitalization, intensive care, and mortality among patients with COVID-19 [1-9]. These risk signals persist after adjusting for age, sex, and major comorbidities including diabetes and chronic cardiac, pulmonary, and kidney disease [1, 2]. Given this evidence, the United States Centers for Disease Control and Prevention has highlighted obesity (BMI ≥30 kg/m2) as a risk factor for severe COVID-19 [10]. We explore multiple causative pathways by which obesity may worsen risk.

Source: Metabolism - Clinical and Experimental - July 12, 2020 Category: Biomedical Science Authors: Matthew J. Townsend, Theodore K. Kyle, Fatima C. Stanford Tags: COVID-19, obesity, and weight stigma Source Type: research